Projects per year
Fingerprint
Dive into the research topics where Elodie Viry is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
TARGET-CLL: DEVELOPMENT OF NEW TOOLS AND THERAPEUTICS FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Moussay, E., Paggetti, J. & Viry, E.
1/02/23 → 31/01/25
Project: Research
-
Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses
Gargiulo, E., Viry, E., Morande, P. E., Largeot, A., Gonder, S., Xian, F., Ioannou, N., Benzarti, M., Kleine Borgmann, F. B., Mittelbronn, M., Dittmar, G., Nazarov, P. V., Meiser, J., Stamatopoulos, B., Ramsay, A. G., Moussay, E. & Paggetti, J., 6 Jan 2023, In: Blood cancer discovery. 4, 1, p. 54-77 24 p.Research output: Contribution to journal › Article › Research › peer-review
-
PKM2 diverts glycolytic flux in dependence on formate overflow
Benzarti, M., Oudin, A., Viry, E., Gargiulo, E., Schmoetten, M., Neises, L., Pulido, C., Lorenz, N. I., Ronellenfitsch, M. W., Sumpton, D., Warmoes, M., Jaeger, C., Lesur, A., Paggetti, J., Moussay, E., Niclou, S. P., Letellier, E. & Meiser, J., 23 Jan 2023, p. 2023-2021, 3 p. (bioRxiv).Research output: Working paper › Preprint
Open Access -
Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Messai, Y., Noman, M. Z., Hasmim, M., Janji, B., Tittarelli, A., Boutet, M., Baud, V., Viry, E., Billot, K., Nanbakhsh, A., Safta, T. B., Richon, C., Ferlicot, S., Donnadieu, E., Couve, S., Gardie, B., Orlanducci, F., Albiges, L., Thiery, J., Olive, D., & 2 others, 15 Apr 2022, In: Cancer Research. 82, 8, p. 1671 1 p.Research output: Contribution to journal › Editorial
Open Access -
Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo
Gargiulo, E., Viry, E., Moussay, E. & Paggetti, J., 27 Sept 2022, In: OncoImmunology. 11, 1, p. 2127507 2127507.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Targeting translation by disrupting the newly identified prohibitin-eif4f complex as a novel therapeutic strategy in chronic lymphocytic leukemia
Largeot, A., Klapp, V., Gonder, S., Viry, E., Szpakowska, M., Hernandez, D. P., Dittmar, G., Chevigné, A., Ysebaert, L. & Stamatopoulos, B., Jun 2022, In: HemaSphere. 6, Suppl.3, p. 518-519 2 p., P619.Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access